Aspirin, NSAID Risks Outweigh Colon Cancer Benefits – AHRQ Task Force
This article was originally published in The Tan Sheet
Executive Summary
A panel of prevention and primary care experts sponsored by the Agency for Healthcare Research and Quality is recommending against the use of aspirin and non-steroidal anti-inflammatory drugs for primary prevention of colorectal cancer
You may also be interested in...
Long-Term Aspirin Use Reduces Colorectal Cancer Risk – Nurses’ Health Study
Women who took more than 14 aspirin per week for 10 years or more demonstrated a 33% lower risk for colorectal cancer compared to nonusers, according to a study published in the Aug. 24-31 Journal of the American Medical Association
Avoiding GMP “Showstoppers” Keeps Manufacturers Off FDA’s “Radar”
Compliance consultants warn that certain dietary supplement good manufacturing practices violations are inspection "showstoppers" and will draw agency enforcement
Avoiding GMP “Showstoppers” Keeps Manufacturers Off FDA’s “Radar”
Compliance consultants warn that certain dietary supplement good manufacturing practices violations are inspection "showstoppers" and will draw agency enforcement
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: